Skip to main content
logo
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.000
-0.130 (-3.15%)
At close: Nov 2, 2026, 4:00 PM EST
4.000
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:00 PM EST

Taysha Gene Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-149.63-109-89.3-111.57-166.01-174.52
Depreciation & Amortization
1.171.151.251.371.170.49
Other Amortization
0.150.15-0.87--
Asset Writedown & Restructuring Costs
334.844.5737.679.75
Stock-Based Compensation
18.1713.313.17.9118.0418.18
Other Operating Activities
-2.123.691.3541.852.220.39
Change in Accounts Payable
1.77-0.15-2.92-2.3-7.814.49
Change in Unearned Revenue
-5.49-9.77-8.33-15.4533.56-
Change in Other Net Operating Assets
0.794.56-1.21-0.27-7.2414.17
Operating Cash Flow
-132.19-93.09-81.23-73.02-88.39-117.04
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.38-0.74-0.37-3.87-20.62-15.3
Sale (Purchase) of Intangibles
-3---3.5-4.25-6.25
Other Investing Activities
0.060.130.010.02-0.06-
Investing Cash Flow
-3.32-0.6-0.36-7.35-24.93-21.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-49.85-39.55-39.96
Total Debt Issued
49.8549.85-39.55-39.96
Long-Term Debt Repaid
--40.61--43--
Total Debt Repaid
-40.61-40.61--43--
Net Debt Issued (Repaid)
9.249.24--3.45-39.96
Issuance of Common Stock
266.71265.6976.87140.8653.5-
Other Financing Activities
-0.23-0.34-0.19-1.02-1.4-0.87
Financing Cash Flow
275.72274.5976.68136.3952.139.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
140.21180.9-4.956.02-61.22-99.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-132.57-93.83-81.6-76.89-109.01-132.35
Free Cash Flow Growth
------
Free Cash Flow Margin
-2416.99%-960.07%-979.23%-497.62%-4356.88%-
Free Cash Flow Per Share
-0.37-0.29-0.33-0.66-2.48-3.52
Levered Free Cash Flow
-80.97-56.7-48.15-68.51-75.31-71.32
Unlevered Free Cash Flow
-81.09-56.81-48.09-66.25-72.94-70.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.75.45.284.952.780.64
Change in Working Capital
-2.92-5.37-12.47-18.0118.5228.67
SEC Filings: 10-K · 10-Q